Approximately 15,000 persons aged <20 years receive a cancer diagnosis each year in
the United States (
1
). National surveillance data could provide understanding of geographic variation
in occurrence of new cases to guide public health planning and investigation (
2
,
3
). Past research on pediatric cancer incidence described differences by U.S. Census
region but did not provide state-level estimates (
4
). To adequately describe geographic variation in cancer incidence among persons aged
<20 years in the United States, CDC analyzed data from United States Cancer Statistics
(USCS) during 2003–2014 and identified 171,432 cases of pediatric cancer during this
period (incidence = 173.7 cases per 1 million persons). The cancer types with the
highest incidence rates were leukemias (45.7), brain tumors (30.9), and lymphomas
(26.2). By U.S. Census region, pediatric cancer incidence was highest in the Northeast
(188.0) and lowest in the South (168.0), whereas by state (including the District
of Columbia [DC]), rates were highest in New Hampshire, DC, and New Jersey. Among
non-Hispanic whites (whites) and non-Hispanic blacks (blacks), pediatric cancer incidence
was highest in the Northeast, and the highest rates among Hispanics were in the South.
The highest rates of leukemia were in the West, and the highest rates of lymphoma
and brain tumors were in the Northeast. State-based differences in pediatric cancer
incidence could guide interventions related to accessing care (e.g., in states with
large distances to pediatric oncology centers), clinical trial enrollment, and state
or regional studies designed to further explore variations in cancer incidence.
USCS includes incidence data from CDC’s National Program of Cancer Registries (NPCR)
and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER)
program (
1
). Data on new cases of cancer diagnosed during 2003–2014 were obtained from population-based
cancer registries affiliated with NPCR and SEER programs in all U.S. states and DC.
This study included incidence data for all registries that met USCS publication criteria*
during 2003–2014, which represented >99% of the U.S. population, excluding data only
from Nevada, which did not meet criteria in 2011. This report includes all cases of
malignant
†
cancer diagnosed among persons aged <20 years; it includes first primary cases only
and excludes recurrent cases. Diagnosis histology and primary site were grouped according
to the International Classification of Childhood Cancer (ICCC).
§
Pediatric cancer rates were expressed per 1 million persons and were age-adjusted
to the 2000 U.S. standard population.
¶
Rates were estimated by sex, age group, race/ethnicity, state, U.S. Census region,**
county-level economic status, county-level rural/urban classification, and ICCC group.
During 2003–2014, CDC identified 171,432 new cases of pediatric cancer (Table 1).
Overall incidence was 173.7 cases per 1 million population. The cancer types with
the highest incidence rates were leukemias (45.7 per 1 million), brain tumors (30.9),
and lymphomas (26.2). Rates were higher in males (181.5) than in females (165.5) and
in persons aged 0–4 years (228.9) and 15–19 years (213.3) than in persons aged 5–9
years (122.6) and 10–14 years (133.0). Among all racial/ethnic groups, the highest
incidence rate was among whites (184.4), and the lowest was among blacks (133.3).
TABLE 1
Age-adjusted incidence rate* of cancer
†
among persons aged <20 years, by U.S. Census region
§
— United States,
¶
2003–2014
U.S. Census region
Total
Northeast
Midwest
South
West
Characteristic
No.
Rate (95% CI)
No.
Rate (95% CI)
No.
Rate (95% CI)
No.
Rate (95% CI)
No.
Rate (95% CI)
Overall
171,432
173.7 (172.9–174.5)
31,893
188.0 (185.9–190.0)
37,702
172.9 (171.1–174.6)
61,998
168.0 (166.7–169.3)
39,839
172.9 (171.2–174.6)
Sex
Male
91,667
181.5 (180.3–182.7)
16,860
194.5 (191.6–197.5)
20,228
180.3 (178.8–182.8)
33,045
175.1 (173.3–177.0)
21,534
182.3 (179.9–184.8)
Female
79,765
165.5 (164.3–166.6)
15,033
181.1 (178.2–184.0)
17,474
164.3 (161.6–166.5)
28,953
160.6 (158.7–162.4)
18,305
163.0 (160.7–165.4)
Age group (yrs)
0–4
54,419
228.9 (227.0–230.8)
9,467
242.7 (237.9–247.7)
12,001
227.0 (228.3–230.6)
20,161
222.7 (219.7–225.8)
12,790
226.1 (222.2–230.0)
5–9
29,181
122.6 (121.2–124.1)
5,161
128.7 (125.2–132.3)
6,323
121.2 (116.7–124.6)
10,862
121.4 (119.1–123.7)
6,835
123.2 (120.3–126.1)
10–14
33,042
133.0 (131.5–134.4)
6,256
145.1 (141.5–148.7)
7,128
131.5 (126.0–134.0)
12,042
130.4 (128.1–132.7)
7,616
131.9 (128.9–134.8)
15–19
54,790
213.3 (211.5–215.1)
11,009
238.5 (234.0–243.0)
12,250
211.5 (210.0–215.5)
18,933
200.5 (197.7–203.4)
12,598
213.5 (209.8–217.3)
Race/Ethnicity**
White
103,650
184.4 (183.3–185.5)
21,580
200.8 (198.1–203.5)
28,309
183.3 (177.7–185.9)
34,798
178.9 (177.0–180.8)
18,963
184.9 (182.3–187.5)
Black
20,188
133.3 (131.5–135.2)
3,402
143.6 (138.8–148.5)
3,894
131.5 (125.4–135.6)
11,194
131.9 (129.5–134.4)
1,698
132.7 (126.4–139.1)
Hispanic
36,197
168.9 (167.2–170.7)
4,758
170.0 (165.2–175.0)
3,473
167.2 (153.5–170.2)
13,250
175.5 (172.5–178.5)
14,716
165.6 (162.9–168.3)
AI/AN
1,507
147.6 (140.2–155.2)
53
93.1 (69.7–121.9)
262
140.2 (118.9–155.2)
450
143.7 (130.7–157.6)
742
162.3 (150.8–174.5)
API
7,089
144.6 (141.2–148.0)
1,488
151.8 (144.2–159.8)
937
141.2 (133.6–148.0)
1,402
127.7 (121.1–134.6)
3,262
150.4 (145.3–155.7)
County-level economic status by percentile††
≤25%
19,536
165.7 (163.4–168.0)
1,848
173.7 (165.9–181.9)
2,888
163.4 (162.3–168.7)
9,902
164.6 (161.3–167.8)
4,898
163.9 (159.3–168.5)
25–75%
98,385
171.3 (170.2–172.4)
15,032
182.2 (179.3–185.1)
21,073
170.2 (167.2–172.8)
38,515
167.8 (166.2–169.5)
23,765
172.1 (169.9–174.3)
≥75%
48,268
181.8 (180.2–183.4)
14,996
196.1 (193.0–199.3)
8,894
180.2 (175.8–183.3)
13,252
171.7 (168.8–174.7)
11,126
178.5 (175.2–181.9)
County-level rural/urban continuum††
Metropolitan population ≥1 million
93,181
177.1 (176.0–178.3)
21,451
189.2 (186.6–191.7)
15,634
176.0 (171.5–178.0)
31,810
172.0 (170.2–173.9)
24,286
175.9 (173.6–178.1)
Metropolitan population 250,000 to <1 million
35,919
171.1 (169.4–172.9)
6,283
184.7 (180.2–189.4)
6,290
169.4 (169.1–172.7)
14,186
164.3 (161.6–167.0)
9,160
172.0 (168.5–175.6)
Metropolitan population <250,000
14,349
165.7 (163.0–168.4)
1,556
183.3 (174.2–192.7)
3,958
163.0 (161.0–168.4)
5,721
162.2 (158.0–166.5)
3,114
164.0 (158.3–169.8)
Nonmetropolitan counties
22,962
167.2 (165.0–169.3)
2,586
188.8 (181.5–196.3)
6,982
165.0 (165.3–169.3)
10,173
163.0 (159.9–166.2)
3,221
160.8 (155.3–166.4)
Sources: CDC’s National Program of Cancer Registries; National Cancer Institute’s
Surveillance, Epidemiology, and End Results Program.
Abbreviations: AI/AN = American Indian/Alaska Native; API = Asian/Pacific Islander;
CI = confidence interval.
* Rates are per 1 million persons and age-adjusted to the 2000 U.S. standard population.
† Cases included all malignant cancers (with behavior code = 3) as grouped by the
International Classification of Childhood Cancer.
§ Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York,
Pennsylvania, Rhode Island, and Vermont. Midwest: Illinois, Indiana, Iowa, Kansas,
Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin.
South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky,
Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee,
Texas, Virginia, and West Virginia. West: Alaska, Arizona, California, Colorado, Hawaii,
Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
¶ Incidence data are compiled from cancer registries that meet the data quality criteria
for all years 2003–2014 (covering >99% of the U.S. population). Nevada is excluded.
Registry-specific data quality information is available at https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2014-technical-notes.pdf.
Characteristic values with other, missing, or blank results are not included in this
table.
** White, black, AI/AN, and API persons are non-Hispanic. Hispanic persons might be
of any race. Counts exclude unspecified or unknown race/ethnicity.
†† Excludes Kansas, Minnesota, and Nevada.
Rates were highest in the Northeast U.S. Census region, followed by the Midwest, the
West, and the South. Rates were highest in the Northeast across all age groups and
among whites and blacks. Among Hispanics, rates were highest in the South. Pediatric
cancer incidence rates were highest in the 25% of counties with the highest economic
status and were higher in metropolitan areas with populations ≥1 million than in nonmetropolitan
areas.
By state, pediatric cancer incidence rates ranged from 145.2–205.5 per 1 million.
Rates were highest in New Hampshire (205.5), DC (194.0), and New Jersey (192.3) and
lowest in South Carolina (149.3) and Mississippi (145.2) (Table 2). Incidence among
whites ranged from 157.0 in Montana to 255.2 in Hawaii; among blacks, from 105.8 in
Rhode Island to 161.3 in Nebraska; and among Hispanics, from 75.0 in Hawaii to 191.8
in Florida.
††
Although incidence rates were highest among children aged 0–4 years overall, in some
states (e.g., New Jersey, New York, and Illinois), the highest rates were among persons
aged 15–19 years (Supplementary Table 1, https://stacks.cdc.gov/view/cdc/53585).
TABLE 2
Age-adjusted incidence rate* of cancer
†
among persons aged <20 years, by state, overall and by race/ethnicity — United States,
§
2003–2014
Total
Race/Ethnicity¶
White
Black
Hispanic
AI/AN
API
State**
No.
Rate (95% CI)
No.
Rate (95% CI)
No.
Rate (95% CI)
No.
Rate (95% CI)
No.
Rate (95% CI)
No.
Rate (95% CI)
Northeast
Connecticut
2,060
185.8 (177.8–194.0)
1,399
194.8 (184.7–205.4)
199
144.6 (125.2–166.3)
361
176.8 (159.0–196.1)
—††
—††
63
133.1 (102.2–170.5)
Maine
725
190.5 (176.9–205.0)
685
194.8 (180.4–210.0)
—††
—††
—††
—††
—††
—††
—††
—††
Massachusetts
3,584
181.5 (175.6–187.5)
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
New Hampshire
816
205.5 (191.6–220.2)
746
207.6 (192.9–223.2)
—††
—††
31
177.8 (120.6–252.5)
—††
—††
18
157.1 (92.6–249.7)
New Jersey
5,308
192.3 (187.1–197.5)
3,168
211.8 (204.4–219.3)
633
148.6 (137.2–160.6)
1,043
175.2 (164.7–186.2)
—§§
—§§
345
145.7 (130.7–162.0)
New York
11,378
190.0 (186.5–193.5)
6,679
209.3 (204.3–214.4)
1,538
147.9 (140.6–155.5)
2,290
175.9 (168.7–183.2)
—§§
—§§
701
164.5 (152.5–177.1)
Pennsylvania
7,167
186.6 (182.3–191.0)
—§§
—§§
—§§
—§§
494
150.6 (137.6–164.6)
—§§
—§§
—§§
—§§
Rhode Island
547
170.0 (156.0–185.0)
429
196.3 (177.9–216.0)
28
105.8 (70.2–153.0)
59
96.8 (73.7–124.9)
—††
—††
—††
—††
Vermont
308
164.2 (146.2–183.9)
299
171.1 (152.0–191.9)
—††
—††
—††
—††
—††
—††
—††
—††
Midwest
Illinois
7,227
171.8 (167.9–175.8)
4,320
183.9 (178.4–189.4)
934
124.4 (116.5–132.7)
1,548
171.2 (162.8–180.0)
—§§
—§§
273
146.7 (129.7–165.2)
Indiana
3,691
171.5 (166.0–177.2)
2,957
178.4 (172.0–185.0)
336
127.6 (114.4–142.1)
296
160.7 (142.7–180.4)
—††
—††
55
139.2 (104.7–181.3)
Iowa
1,762
178.6 (170.4–187.2)
1,508
181.2 (172.1–190.6)
60
115.7 (88.2–149.1)
130
166.2 (138.6–197.8)
—††
—††
30
140.0 (94.3–200.1)
Kansas
1,713
177.0 (168.8–185.6)
—§§
—§§
—§§
—§§
254
172.8 (152.0–195.7)
—§§
—§§
—§§
—§§
Michigan
5,786
178.9 (174.3–183.6)
4,339
188.1 (182.6–193.8)
826
140.5 (131.1–150.4)
296
135.8 (120.7–152.3)
34
127.1 (87.8–178.1)
116
122.3 (101.1–146.8)
Minnesota
3,109
179.9 (173.6–186.3)
2,420
181.4 (174.3–188.8)
177
122.8 (105.2–142.4)
203
162.6 (140.6–187.0)
46
159.1 (116.4–212.2)
159
162.2 (137.9–189.5)
Missouri
3,120
163.1 (157.4–168.9)
2,481
168.9 (162.3–175.6)
400
135.8 (122.8–149.8)
139
137.2 (115.0–162.3)
—††
—††
44
116.5 (84.6–156.5)
Nebraska
1,133
183.2 (172.7–194.2)
868
184.9 (172.8–197.7)
69
161.3 (125.3–204.2)
142
165.8 (139.2–196.0)
—††
—††
20
151.2 (92.2–233.7)
North Dakota
341
158.7 (142.3–176.6)
295
163.4 (145.2–183.2)
—††
—††
—††
—††
33
174.0 (119.6–244.7)
—††
—††
Ohio
6,225
168.3 (164.1–172.5)
4,999
175.6 (170.8–180.6)
751
124.5 (115.8–133.7)
206
122.2 (105.9–140.3)
—††
—††
106
147.5 (120.7–178.6)
South Dakota
413
150.3 (136.1–165.5)
347
162.4 (145.8–180.5)
—††
—††
—††
—††
49
126.9 (93.8–167.8)
—††
—††
Wisconsin
3,182
175.6 (169.5–181.8)
2,525
181.9 (174.8–189.1)
220
125.1 (109.1–142.7)
247
154.7 (135.7–175.4)
41
181.8 (130.3–246.7)
92
150.1 (120.9–184.1)
South
Alabama
2,377
157.0 (150.7–163.4)
1,600
172.2 (163.8–180.8)
619
129.4 (119.4–140.1)
102
124.4 (100.7–152.0)
—††
—††
25
133.2 (86.1–196.8)
Arkansas
1,523
161.7 (153.7–170.1)
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
Delaware
504
180.9 (165.5–197.5)
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
District of Columbia
306
194.0 (172.6–217.3)
77
215.2 (165.9–274.7)
152
152.0 (128.7–178.2)
28
159.2 (104.6–231.4)
—††
—††
—††
—††
Florida
9,160
169.9 (166.4–173.4)
4,625
174.8 (169.8–179.9)
1,526
130.9 (124.4–137.6)
2,714
191.8 (184.7–199.2)
—††
—††
165
111.9 (95.5–130.4)
Georgia
5,291
161.9 (157.6–166.3)
2,884
177.1 (170.7–183.6)
1,556
136.2 (129.5–143.2)
634
166.9 (153.8–180.7)
—††
—††
159
144.2 (122.6–168.4)
Kentucky
2,377
174.4 (167.4–181.5)
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
—§§
Louisiana
2,378
156.9 (150.7–163.4)
1,453
177.7 (168.7–187.1)
753
127.1 (118.2–136.5)
113
164.2 (134.8–198.0)
—††
—††
42
173.9 (125.3–235.1)
Maryland
2,942
160.0 (154.2–165.9)
1,664
179.7 (171.2–188.6)
773
125.1 (116.4–134.3)
286
156.0 (138.1–175.4)
—††
—††
99
95.1 (77.2–115.8)
Mississippi
1,476
145.2 (137.9–152.8)
860
166.0 (155.1–177.5)
548
121.7 (111.7–132.4)
45
138.5 (100.2–186.3)
—††
—††
—††
—††
North Carolina
4,834
161.6 (157.1–166.2)
3,052
175.2 (169.0–181.5)
991
129.3 (121.4–137.7)
560
155.6 (142.6–169.4)
38
88.7 (62.8–121.8)
111
138.6 (113.9–167.1)
Oklahoma
2,082
168.3 (161.1–175.6)
1,273
166.1 (157.0–175.4)
170
131.0 (112.0–152.2)
276
168.9 (149.2–190.4)
296
194.1 (172.6–217.5)
36
142.5 (99.8–197.4)
South Carolina
2,162
149.3 (143.1–155.8)
1,370
164.7 (156.1–173.6)
600
122.2 (112.6–132.4)
149
154.4 (130.0–182.0)
—††
—††
24
114.2 (73.1–170.0)
Tennessee
3,411
172.1 (166.4–178.0)
2,500
180.4 (173.4–187.6)
614
144.5 (133.3–156.4)
211
160.4 (138.7–184.4)
—††
—††
48
142.2 (104.7–188.6)
Texas
16,368
183.2 (180.4–186.0)
6,598
200.7 (195.8–205.6)
1,571
140.0 (133.1–147.1)
7,503
179.7 (175.6–183.8)
47
162.0 (118.8–216.0)
431
134.0 (121.6–147.3)
Virginia
3,899
156.4 (151.5–161.4)
2,553
169.2 (162.7–175.9)
710
124.1 (115.1–133.6)
355
139.1 (124.8–154.5)
—††
—††
175
118.2 (101.3–137.1)
West Virginia
908
172.0 (160.9–183.5)
855
175.4 (163.8–187.5)
28
110.2 (73.1–159.3)
—††
—††
—††
—††
—††
—††
West
Alaska
424
169.4 (153.6–186.3)
232
158.0 (138.3–179.7)
—††
—††
25
138.7 (89.5–204.3)
115
217.2 (179.3–260.7)
40
232.0 (165.7–316.0)
Arizona
3,590
168.8 (163.3–174.4)
1,683
176.1 (167.8–184.7)
130
122.4 (102.2–145.3)
1,454
164.4 (156.1–173.1)
199
164.2 (142.1–188.7)
79
132.7 (105.0–165.5)
California
21,725
173.2 (170.9–175.6)
7,505
189.9 (185.6–194.2)
1,184
137.9 (130.1–146.0)
10,525
170.1 (166.9–173.4)
101
138.7 (112.8–168.8)
2,187
148.3 (142.1–154.6)
Colorado
2,767
171.3 (165.0–177.8)
1,754
175.6 (167.4–184.0)
103
121.7 (99.3–147.6)
762
162.4 (151.1–174.5)
20
153.2 (93.2–237.6)
88
171.8
Hawaii
652
160.1 (148.0–172.9)
134
255.2 (213.7–302.4)
—††
—††
46
75.0 (54.3–101.0)
—††
—††
439
155.6
Idaho
941
170.0 (159.3–181.3)
789
178.3 (166.0–191.2)
—††
—††
121
136.5 (113.1–163.3)
—††
—††
—††
—††
Montana
488
160.2 (146.2–175.0)
398
157.0 (141.9–173.2)
—††
—††
24
162.8 (104.0–242.7)
56
182.4 (137.7–237.0)
—††
—††
New Mexico
1,077
157.0 (147.7–166.6)
393
198.7 (179.5–219.4)
20
126.9 (77.5–196.1)
539
139.7 (128.2–152.0)
101
131.0 (106.7–159.2)
16
186.7 (106.6–303.7)
Oregon
2,114
182.6 (174.9–190.6)
1,591
192.1 (182.7–201.8)
40
111.6 (79.7–152.0)
343
155.1 (139.0–172.6)
27
134.5 (88.5–196.4)
81
146.1 (116.0–181.6)
Utah
1,984
178.3 (170.5–186.4)
1,596
182.2 (173.3–191.3)
23
130.1 (82.1–195.9)
309
180.9 (161.1–202.5)
—††
—††
40
120.5 (86.0–164.0)
Washington
3,797
180.7 (175.0–186.5)
2,656
189.8 (182.6–197.2)
163
135.8 (115.8–158.4)
542
146.9 (134.6–159.9)
83
200.1 (159.3–248.2)
276
158.1 (140.0–177.9)
Wyoming
280
156.8 (139.0–176.3)
232
159.1 (139.3–181.0)
—††
—††
26
118.1 (76.8–173.4)
—††
—††
—††
—††
Sources: CDC’s National Program of Cancer Registries; National Cancer Institute’s
Surveillance, Epidemiology, and End Results Program.
Abbreviations: AI/AN = American Indian/Alaska Native; API = Asian/Pacific Islander;
CI = confidence interval.
* Rates are per 1 million persons and age-adjusted to the 2000 U.S. standard population.
† Cases included all malignant cancers (with behavior code = 3) as grouped by the
International Classification of Childhood Cancer.
§ Incidence data are compiled from cancer registries that meet the data quality criteria
for all years 2003–2014 (covering >99% of the U.S. population). Nevada is excluded.
Registry-specific data quality information is available at https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2014-technical-notes.pdf.
¶ White, black, AI/AN, and API are non-Hispanic. Hispanic persons might be of any
race. Counts exclude unspecified or unknown race/ethnicity; the counts in the total
column may not equal the sum of the individual race/ethnicity columns.
** States are grouped by U.S. Census region.
†† Case counts <16 are suppressed.
§§ Race/ethnicity data was suppressed for states that elected to be excluded from
race/ethnicity analysis.
Pediatric cancer incidence rates varied by state within each cancer type (Figure).
Incidence rates were highest in the West for leukemias, myeloproliferative diseases,
and myelodysplastic diseases (ICCC group I) and in the Northeast for lymphomas and
reticuloendothelial neoplasms (group II) and central nervous system cancers (group
III). Rates were also highest in the Northeast for neuroblastoma, retinoblastoma,
bone tumors, soft tissue sarcomas, and thyroid cancer (Supplementary Table 2, https://stacks.cdc.gov/view/cdc/53586).
Renal cancer rates were highest in the Northeast and South; hepatic tumor rates were
highest in the Northeast and West. Germ cell tumor rates were highest in the West
(Supplementary Table 2, https://stacks.cdc.gov/view/cdc/53586).
FIGURE
Age-adjusted incidence* of cancer
†
among persons aged <20 years, by U.S. state and ICCC type — United States,
§
2003–2014
¶
Sources: CDC’s National Program of Cancer Registries; National Cancer Institute’s
Surveillance, Epidemiology, and End Results Program.
Abbreviation: ICCC = International Classification of Childhood Cancer.
* Rates are per 1 million persons and age-adjusted to the 2000 U.S. standard population.
† Cases included all malignant cancers (with behavior code = 3) as grouped by the
ICCC.
§ Solid tumors (Groups IV–XI) include neuroblastoma and other peripheral nervous cell
tumors, retinoblastoma, renal tumors, hepatic tumors, malignant bone tumors, soft
tissue and other extraosseous sarcomas, germ cell and trophoblastic tumors and neoplasms
of gonads, and other malignant epithelial neoplasms and melanomas. The ICCC group
total map includes 258 cases not classified by ICCC.
¶ Incidence data are compiled from cancer registries that meet the data quality criteria
for all years 2003–2014 (covering >99% of the U.S. population). Nevada is excluded.
Registry-specific data quality information is available at https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2014-technical-notes.pdf.
The figure above is a series of maps showing age-adjusted incidence rate of cancer
among persons aged <20 years, by U.S. state and International Classification of Childhood
Cancer type in the United States, during 2003–2014.
Discussion
This study used recent data with greater population coverage than past studies (
4
,
5
) to document geographic variation in pediatric cancer incidence rates by sex, age,
type, and race/ethnicity. Consistent with past reports (
1
,
4
,
5
), pediatric cancer rates were highest in males, persons aged 0–4 years and 15–19
years, whites, and the Northeast U.S. Census region. Rates were highest in metropolitan
areas with populations ≥1 million; state-based rates were highest in New Hampshire,
DC, and New Jersey.
A strength of this report is the use of extensive population-based surveillance data
(>99% coverage
§§
), which permits a detailed description of state-based cancer incidence variation.
Geographic variation in rates might account for differences in results from previous
studies that were based on different populations such as state data (
2
,
3
), SEER registries (which cover 9%–28% of the U.S. population),
¶¶
or other large data sets (
6
). A 2016 study specific to Delaware assessed pediatric cancer incidence by demographic
group and ZIP Code; the study commented on local environmental exposures and possible
incidence disparities based upon sex, age, race/ethnicity, geographic location, and
economic status (
2
). USCS data provide states with a standardized way to gauge whether local pediatric
cancer incidence rates differ relative to other states and might prompt states to
conduct investigations similar to the one performed in Delaware.
Geographic variation in pediatric cancer incidence might be influenced by several
factors.*** First, variation in childhood cancer incidence might be related to differences
in exposures to carcinogenic chemicals (e.g., air pollution, secondhand smoke, food,
or drinking water) or radiation (
7
). Second, genetic variation in certain populations (e.g., prevalence of cancer predisposition
genes) (
2
,
4
,
5
) might contribute to geographic differences in cancer incidence. Third, the rates
of certain cancer types might vary by race/ethnicity. For example, Hispanic children
have the highest rate of the most common type of leukemia, pediatric acute lymphoblastic
leukemia, and states with a higher proportion of Hispanics might have higher rates
of acute lymphoblastic leukemia (
8
). Fourth, incidence of some types of cancer (e.g., thyroid carcinoma) might be related
to enhanced detection and access to care, which can vary by geographic location (
5
,
9
).
In addition, geographic variation might be affected by age, economic status, or rural/urban
classification (
4
,
8
,
10
). Similar to the findings from this report, recent data detailing adult cancers also
indicate that the highest cancer incidence rates are in the Northeast (
10
). Rates of cancer types mostly affecting adults also varied by rural/urban status;
some of these differences in adults might be related to factors such as obesity or
smoking (
10
), which might or might not also explain rural/urban variation in pediatric cancer.
The findings in this report are subject to at least three limitations. First, Nevada
was excluded because data for 2011 did not meet quality criteria, which limits the
representativeness of the findings. Second, differences in diagnosis and cancer reporting
among states might contribute to variation in cancer incidence rates (
8
). For example, states that were early adopters of electronic pathology reporting
might report increased rates because of increased case ascertainment compared with
other states. Finally, misrepresentation of race and ethnicity might exist; rate numerators
might underestimate American Indians, Alaska Natives, and Hispanics, which could artificially
lower rates among these groups; and U.S. Census populations used in rate denominators
might undercount children and Hispanics, which could artificially increase rates in
these populations (
8
).
†††
Knowledge of pediatric cancer incidence variation by state and cancer type can prompt
local and state cancer registries to evaluate reporting and diagnostic standards.
Understanding geographic variation in incidence rates can help cancer control planners
and clinicians address obstacles in access to care, which is especially relevant to
states with large distances to pediatric oncology centers (
3
). Because 5-year pediatric cancer survival is >80%, and most cancer survivors require
close monitoring by specialists throughout life (
5
), state-specific data by cancer type and patient age might help public health planners
address ongoing chronic care needs. In addition, state-specific data by cancer type
and patient age might help clinical trial organizers predict patient accrual. Finally,
health care practitioners and researchers can use these data to guide investigations
related to causes of pediatric cancer incidence variation (
2
,
3
). Continued surveillance will be needed to further validate findings and track geographic
incidence patterns over time.
Summary
What is already known about this topic?
Past research on nationwide pediatric cancer incidence described differences by U.S.
Census region but did not provide state-level estimates.
What is added by this report?
During 2003–2014, the pediatric cancer rate was highest in the Northeast, lowest in
the South, and highest in metropolitan areas with populations ≥1 million and counties
in the top 25% economic status. Incidence rates by state ranged from 145 to 206 per
million and were highest in New Hampshire, the District of Columbia, and New Jersey.
The highest rate of leukemia was in the West; the highest rates of lymphoma and brain
cancer were in the Northeast.
What are the implications for public health practice?
Knowledge of these geographic differences in childhood cancer incidence can be used
to enhance provider awareness, treatment capacity, survivorship care, and cancer surveillance.